Mycronic evaluates listing Axxon
The Board of Mycronic AB (publ) has decided to investigate the possibility of listing Axxon, the core of the High Volume division, on the STAR market of the Shanghai stock exchange and floating a minority stake. If feasible, the listing could take place during 2024.Axxon has developed very successfully since Mycronic’s acquisition in 2016. A net sales compound annual growth rate of 39 percent, with healthy profitability, has brought Axxon to a market leadership position in dispensing for the electronics industry. Axxon has largely operated independently as a Chinese company with its own IP,